Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01858805
NCT01858805CompletedNot Applicable

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country123 target enrollmentStarted: April 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
123
Locations
1
Primary Endpoint
overall survival
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Despite the availability of several preoperative diagnostic techniques, accurate pretreatment staging of esophageal cancer (EC) remains challenging. Therefore, The investigators evaluated the prognostic significance of circulating tumor cells (CTCs) in patients with EC.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •> 18 years
  • •resectable esophageal cancer

Exclusion Criteria

  • •< 18 years
  • •esophageal cancer with preoperative distant metastases

Outcomes

Primary Outcomes

overall survival

Time Frame: 2 years

Secondary Outcomes

  • recurrence-free survival(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. med. Matthias Reeh

MD

Universitätsklinikum Hamburg-Eppendorf

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsNasopharyngeal Neoplasms
NCT02505139Sun Yat-sen University166
Completed
Not Applicable
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerProstate Cancer
NCT05533515Queen Mary University of London330
Terminated
Not Applicable
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.Circulating Tumor CellsPancreatic AdenocarcinomaCirculating Tumor DNA (KRAS)CA 19.9
NCT02072616University Hospital, Rouen101
Completed
Not Applicable
Circulating Tumor Cells in Lung Cancer ScreeningLung NeoplasmsPulmonary Disease, Chronic Obstructive
NCT02500693Centre Hospitalier Universitaire de Nice683
Completed
Not Applicable
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or ChemoradiotherapyNon-small Cell Lung Cancer
NCT02135679Abramson Cancer Center at Penn Medicine204